Lineagen is Laboratory Services (Healthcare) in United States that focus on chromosomal microarray business. Founded in 2006. They cover business area such as developer, a genetic testing technology, child, neurodevelopmental disorder, chromosomal microarray (CMA) testing technology, genetic condition, global developmental delay, nationally accept guideline, physician, medical management, individual, an autism spectrum disorder.
Laboratory Services (Healthcare)
2006
( 18 years old in 2024 )
Chromosomal Microarray
-
2677 East Parleys Way
Salt Lake City, UT 84109
United States
Private
developera genetic testing technologychildneurodevelopmental disorderchromosomal microarray (CMA) testing technologygenetic conditionglobal developmental delaynationally accept guidelinephysicianmedical managementindividualan autism spectrum disorder
* We use standard office opening hours in near Lineagen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lineagen is Laboratory Services (Healthcare) business from United States that founded in 2006 (18 years old in 2024), Lineagen business is focusing on Chromosomal Microarray.
Lineagen headquarter office and corporate office address is located in 2677 East Parleys Way Salt Lake City, UT 84109 United States.
Lineagen was founded in United States.
In 2024, Lineagen is currently focus on chromosomal microarray sector.
Above is snippet of Google Trends for "chromosomal microarray" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lineagen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
